STOCK TITAN

Actuate Therapeutics (NASDAQ: ACTU) director receives grant of 15,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACTUATE THERAPEUTICS, INC. director and ten percent owner Aaron G.L. Fletcher received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $2.4200 per share, expire on May 21, 2036, and will vest in full on the first anniversary of the grant date. Following this grant, Fletcher holds 15,000 stock options directly.

Positive

  • None.

Negative

  • None.
Insider Fletcher Aaron G.L.
Role null
Type Security Shares Price Value
Grant/Award Stock Options 15,000 $0.00 --
Holdings After Transaction: Stock Options — 15,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 15,000 options Stock options covering common stock granted to Fletcher
Exercise price $2.4200 per share Exercise price for underlying common stock
Underlying shares 15,000 shares Common stock underlying granted options
Expiration date May 21, 2036 Options expiration
Options held after grant 15,000 options Total derivative holdings following transaction
Stock Options financial
"security_title: "Stock Options""
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price: "2.4200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-05-21T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"Options will vest in full on the anniversary of the grant date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fletcher Aaron G.L.

(Last)(First)(Middle)
C/O ACTUATE THERAPEUTICS, INC.
1751 RIVER RUN, SUITE 400

(Street)
FORT WORTH TEXAS 76107

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ACTUATE THERAPEUTICS, INC. [ ACTU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$2.4205/21/2026A15,000 (1)05/21/2036Common Stock15,000$015,000D
Explanation of Responses:
1. Options will vest in full on the anniversary of the grant date.
/s/ Paul Lytle, Attorney-in-Fact05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did ACTU (Actuate Therapeutics) insider Aaron G.L. Fletcher report on this Form 4?

Aaron G.L. Fletcher reported receiving a grant of stock options covering 15,000 shares of Actuate Therapeutics common stock. These options were acquired as a compensation award rather than through an open-market purchase or sale transaction.

How many ACTU stock options were granted to Aaron G.L. Fletcher?

Aaron G.L. Fletcher was granted stock options on 15,000 underlying shares of Actuate Therapeutics common stock. This entire amount was acquired in a single derivative transaction, with 15,000 options shown as held following the grant.

What is the exercise price of Aaron G.L. Fletcher’s ACTU stock options?

The stock options granted to Aaron G.L. Fletcher have an exercise price of $2.4200 per share. This is the price he would pay per share of common stock if he chooses to exercise the options in the future.

When do Aaron G.L. Fletcher’s ACTU stock options expire?

Aaron G.L. Fletcher’s stock options expire on May 21, 2036. After this expiration date, any unexercised options will no longer be exercisable, effectively ending his right to purchase shares under this particular grant.

How and when do Aaron G.L. Fletcher’s ACTU stock options vest?

The options will vest in full on the anniversary of the grant date, according to the footnote. This means 100% of the 15,000 options become exercisable on the one-year mark from the grant, assuming applicable service conditions are satisfied.

Is this ACTU Form 4 transaction a market buy or sell of shares?

No, this Form 4 reports a grant or award acquisition of stock options, not an open-market trade. The transaction code “A” reflects a compensation-related award, and the price per option is listed as $0.0000, indicating no cash paid for the grant itself.